Literature DB >> 19531679

Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.

Hong-Li Xu1, Wang-Hong Xu, Qiuyin Cai, Min Feng, Jirong Long, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu.   

Abstract

Caspase-3, caspase-7, and caspase-8 are important caspases in the apoptosis pathway and play an important role in the development and progression of cancer. We examined the association between genetic variants in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer among Chinese women. Genotypes for 1,028 women with endometrial cancer and 1,003 healthy controls were determined with the Affymetrix MegAllele Targeted Genotyping System and Molecular Inversion Probe method. Of 35 selected single-nucleotide polymorphisms, four in the caspase-7 gene were in high linkage disequilibrium (rs11593766, rs3124740, rs11196445, and rs11196418) and associated with the risk for endometrial cancer. The AA genotype of rs11196418 [odds ratio, 0.36; 95% confidence interval (95% CI), 0.14-0.94] and the G allele of rs11593766 were associated with reduced risk (odds ratio of 0.75 and 95% CI of 0.59-0.96 for carriers of one G allele; odds ratio of 0.70 and 95% CI of 0.24-2.03 for carriers of two G alleles). The AA genotype of rs11196445 (odds ratio, 1.74; 95% CI, 0.99-3.05), the CC genotype of rs3124740 (odds ratio, 1.36; 95% CI, 1.06-1.75), and the GG genotype of rs10787498 in the caspase-7 gene (odds ratio, 1.90; 95% CI, 1.16-3.11) were associated with increased risk compared with homozygotes of the major alleles. The gene-disease association seemed to be more pronounced among premenopausal women, although tests for multiplicative interaction between genes and menopausal status failed to reach statistical significance. The GG genotype of rs2705901 in the caspase-3 gene was significantly associated with increased cancer risk compared with the CC genotype (odds ratio, 2.25; 95% CI, 1.03-4.95). No association was observed between polymorphisms of the caspase-8 gene and risk for endometrial cancer. These findings suggest that genetic variants in caspase-3 and caspase-7 may play a role in endometrial cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531679      PMCID: PMC2764360          DOI: 10.1158/1055-9965.EPI-09-0152

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

Review 1.  Mechanisms of caspase activation.

Authors:  Kelly M Boatright; Guy S Salvesen
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 2.  The epidemiology of endometrial cancer.

Authors:  F Parazzini; C La Vecchia; L Bocciolone; S Franceschi
Journal:  Gynecol Oncol       Date:  1991-04       Impact factor: 5.482

3.  Loss of caspase-2, -6 and -7 expression in gastric cancers.

Authors:  Nam Jin Yoo; Jong Woo Lee; Yun Ju Kim; Young Hwa Soung; Su Young Kim; Suk Woo Nam; Won Sang Park; Jung Young Lee; Sug Hyung Lee
Journal:  APMIS       Date:  2004-06       Impact factor: 3.205

Review 4.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

5.  Inactivating mutations of CASPASE-7 gene in human cancers.

Authors:  Young Hwa Soung; Jong Woo Lee; Hong Sug Kim; Won Sang Park; Su Young Kim; Jong Heun Lee; Jik Young Park; Yong Gu Cho; Chang Jae Kim; Yong Gyu Park; Suk Woo Nam; Seong Whan Jeong; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

6.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

7.  Molecular mechanism of apoptosis: prediction of three-dimensional structure of caspase-6 and its interactions by homology modeling.

Authors:  Rabia Sattar; S Abid Ali; Atiya Abbasi
Journal:  Biochem Biophys Res Commun       Date:  2003-08-29       Impact factor: 3.575

8.  Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Authors:  Apinya Thiantanawat; Brian J Long; Angela M Brodie
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

9.  Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth.

Authors:  E Robert McDonald; Wafik S El-Deiry
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

10.  Caspase-3 expression in human gastric carcinoma and its clinical significance.

Authors:  Naoki Isobe; Hisashi Onodera; Akira Mori; Yutaka Shimada; Weige Yang; Seiichi Yasuda; Akihisa Fujimoto; Hideaki Ooe; Shigeki Arii; Masanori Kitaichi; Masayuki Imamura
Journal:  Oncology       Date:  2004       Impact factor: 2.935

View more
  15 in total

1.  A Large-scale genetic association study of esophageal adenocarcinoma risk.

Authors:  Chen-Yu Liu; Michael C Wu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Rihong Zhai; Zhaoxi Wang; Li Su; Rebecca S Heist; Matthew H Kulke; Xihong Lin; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2010-05-07       Impact factor: 4.944

2.  CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.

Authors:  Ming Yin; Jingrong Yan; Sheng Wei; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

Review 3.  Caspase functions in cell death and disease.

Authors:  David R McIlwain; Thorsten Berger; Tak W Mak
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

4.  CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Limei Luo; Yonggang Wei; Bo Li; Hanteng Yang
Journal:  Tumour Biol       Date:  2016-01-12

Review 5.  Therapeutic effect of metformin in the treatment of endometrial cancer.

Authors:  Nan Mu; Tingting Xu; Mingxiao Gao; Mei Dong; Qing Tang; Li Hao; Guiqing Wang; Zenghui Li; Wenshuang Wang; Ying Yang; Jianqing Hou
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

6.  Initiator and executioner caspases in salivary gland apoptosis of Rhipicephalus haemaphysaloides.

Authors:  Yanan Wang; Shanming Hu; Mayinuer Tuerdi; Xinmao Yu; Houshuang Zhang; Yongzhi Zhou; Jie Cao; Itabajara da Silva Vaz; Jinlin Zhou
Journal:  Parasit Vectors       Date:  2020-06-05       Impact factor: 3.876

7.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

Review 8.  Old, new and emerging functions of caspases.

Authors:  S Shalini; L Dorstyn; S Dawar; S Kumar
Journal:  Cell Death Differ       Date:  2014-12-19       Impact factor: 15.828

9.  Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk.

Authors:  I-Chen Wu; Yang Zhao; Rihong Zhai; Chen-yu Liu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Li Su; Rebecca S Heist; Matthew H Kulke; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2011-01-06       Impact factor: 4.944

10.  MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents.

Authors:  Mohammed Arif; Raghav Pandey; Perwez Alam; Shujia Jiang; Sakthivel Sadayappan; Arghya Paul; Rafeeq P H Ahmed
Journal:  J Mol Med (Berl)       Date:  2017-09-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.